4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-14-074595
Options or other derivatives
- SVP & Chief Financial Officer acquired 175,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Nicholson John · SVP & Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2014-12-09 | Grant or award : show line 1 in the form Stock Option | +87,500 | $16.31 | 2022-12-08 | 87,500 | 87,500 | D |
| 2014-12-09 | Grant or award : show line 2 in the form Stock Option | +87,500 | $16.31 | 2022-12-08 | 87,500 | 87,500 | D |
Loading xslF345X03/doc4.xml…